Prenatal opioid exposure: The next neonatal neuroinflammatory disease

[1]  D. Kintner,et al.  Developmental differences in microglia morphology and gene expression during normal brain development and in response to hypoxia-ischemia , 2019, Neurochemistry International.

[2]  E. Melhuish,et al.  Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure , 2019, JAMA network open.

[3]  J. Volpe.  Dysmaturation of Premature Brain: Importance, Cellular Mechanisms, and Potential Interventions. , 2019, Pediatric neurology.

[4]  B. Zuckerman,et al.  Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population , 2019, JAMA network open.

[5]  S. Robinson,et al.  CXCR2 Blockade Mitigates Neural Cell Injury Following Preclinical Chorioamnionitis , 2019, Front. Physiol..

[6]  J. Cavanagh,et al.  Impaired cognitive flexibility following NMDAR-GluN2B deletion is associated with altered orbitofrontal-striatal function , 2019, Neuroscience.

[7]  F. Northington,et al.  Chorioamnionitis in Rats Precipitates Extended Postnatal Inflammatory Lymphocyte Hyperreactivity , 2019, Developmental Neuroscience.

[8]  Gowri Dorairajan,et al.  Fetal inflammatory response syndrome (FIRS) and outcome of preterm neonates – a prospective analytical study , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[9]  J. Stephen,et al.  Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age. , 2019, Early human development.

[10]  E. Letourneau,et al.  Children in the Opioid Epidemic: Addressing the Next Generation’s Public Health Crisis , 2018, Pediatrics.

[11]  F. Chappell,et al.  Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta‐analysis , 2018, Developmental medicine and child neurology.

[12]  P. Gressens,et al.  The Cerebrospinal Fluid Inflammatory Response to Preterm Birth , 2018, Front. Physiol..

[13]  P. Due-Tønnessen,et al.  Neuroanatomical characteristics of youths with prenatal opioid and poly-drug exposure. , 2018, Neurotoxicology and teratology.

[14]  S. Robinson,et al.  Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats , 2018, Front. Neurol..

[15]  William W. Taylor,et al.  Dorsolateral Striatum Engagement Interferes with Early Discrimination Learning , 2018, Cell reports.

[16]  F. Northington,et al.  Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy , 2018, Front. Neurol..

[17]  S. Robinson,et al.  Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury , 2018, Experimental Neurology.

[18]  Amy L. Salisbury,et al.  Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes. , 2018, Drug and alcohol dependence.

[19]  S. Robinson,et al.  Preclinical chorioamnionitis dysregulates CXCL1/CXCR2 signaling throughout the placental-fetal-brain axis , 2018, Experimental Neurology.

[20]  M. Tuten,et al.  Prenatal buprenorphine exposure and neonatal neurobehavioral functioning. , 2018, Early human development.

[21]  Manuel Blesa Cabez,et al.  Prenatal methadone exposure is associated with altered neonatal brain development , 2017, NeuroImage: Clinical.

[22]  H. Jones,et al.  Maternal buprenorphine treatment and infant outcome. , 2017, Drug and alcohol dependence.

[23]  L. Finnegan,et al.  Neonatal abstinence syndrome: where are we, and where do we go from here? , 2017, Current opinion in psychiatry.

[24]  Davida M. Schiff,et al.  Treatment of Opioid Use Disorder During Pregnancy and Cases of Neonatal Abstinence Syndrome. , 2017, JAMA pediatrics.

[25]  T. O'Shea,et al.  Both antenatal and postnatal inflammation contribute information about the risk of brain damage in extremely preterm newborns , 2017, Pediatric Research.

[26]  H. Jones,et al.  Maternal buprenorphine treatment and fetal neurobehavioral development , 2017, American journal of obstetrics and gynecology.

[27]  S. Robinson,et al.  Microstructural and microglial changes after repetitive mild traumatic brain injury in mice , 2017, Journal of neuroscience research.

[28]  D. Agoston.  How to Translate Time? The Temporal Aspect of Human and Rodent Biology , 2017, Front. Neurol..

[29]  H. Bartsch,et al.  Brain morphology in school-aged children with prenatal opioid exposure: A structural MRI study. , 2017, Early human development.

[30]  Davida M. Schiff,et al.  A Public Health Response to Opioid Use in Pregnancy , 2017, Pediatrics.

[31]  K. Walhovd,et al.  Cognitive function of youths born to mothers with opioid and poly-substance abuse problems during pregnancy , 2017, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence.

[32]  E. Melhuish,et al.  Neonatal Abstinence Syndrome and High School Performance , 2017, Pediatrics.

[33]  K. McQueen,et al.  Neonatal Abstinence Syndrome. , 2016, The New England journal of medicine.

[34]  Emma J. Telford,et al.  Association between preterm brain injury and exposure to chorioamnionitis during fetal life , 2016, Scientific Reports.

[35]  Antonis Rokas,et al.  Comprehensive RNA profiling of villous trophoblast and decidua basalis in pregnancies complicated by preterm birth following intra-amniotic infection. , 2016, Placenta.

[36]  H. Jones,et al.  Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta‐analysis of safety in the mother, fetus and child , 2016, Addiction.

[37]  T. O'Shea,et al.  Duration of Systemic Inflammation in the First Postnatal Month Among Infants Born Before the 28th Week of Gestation , 2016, Inflammation.

[38]  R. Tasker,et al.  Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury. , 2016, Journal of neurosurgery. Pediatrics.

[39]  A. Leviton,et al.  Systemic inflammation on postnatal days 21 and 28 and indicators of brain dysfunction 2years later among children born before the 28th week of gestation. , 2016, Early human development.

[40]  N. Joste,et al.  Combined in utero hypoxia-ischemia and lipopolysaccharide administration in rats induces chorioamnionitis and a fetal inflammatory response syndrome. , 2015, Placenta.

[41]  S. Robinson,et al.  Erythropoietin Modulates Cerebral and Serum Degradation Products from Excess Calpain Activation following Prenatal Hypoxia-Ischemia , 2015, Developmental Neuroscience.

[42]  A. Melinder,et al.  Executive function in preschool children prenatally exposed to methadone or buprenorphine , 2015, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence.

[43]  Christopher G. Wilson,et al.  Prenatal Hypoxia–Ischemia Induces Abnormalities in CA3 Microstructure, Potassium Chloride Co-Transporter 2 Expression and Inhibitory Tone , 2015, Front. Cell. Neurosci..

[44]  S. Robinson,et al.  Postnatal Erythropoietin Mitigates Impaired Cerebral Cortical Development Following Subplate Loss from Prenatal Hypoxia-Ischemia. , 2015, Cerebral cortex.

[45]  W. Cooper,et al.  Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012 , 2015, Journal of Perinatology.

[46]  K. Walhovd,et al.  Longitudinal cognitive development of children born to mothers with opioid and polysubstance use , 2015, Pediatric Research.

[47]  F. Harrell,et al.  Prescription Opioid Epidemic and Infant Outcomes , 2015, Pediatrics.

[48]  S. Maier,et al.  Opioid‐Induced Central Immune Signaling: Implications for Opioid Analgesia , 2015, Headache.

[49]  D. Ferriero,et al.  The role of inflammation in perinatal brain injury , 2015, Nature Reviews Neurology.

[50]  Matthew M Davis,et al.  Increasing Incidence and Geographic Distribution of Neonatal Abstinence Syndrome: United States 2009-2012 , 2015, Journal of Perinatology.

[51]  Dionne A. Graham,et al.  Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain. , 2015, Cerebral cortex.

[52]  Meghan T. Frey,et al.  Opioid Prescription Claims Among Women of Reproductive Age — United States, 2008–2012 , 2015, MMWR. Morbidity and mortality weekly report.

[53]  J. Brigman,et al.  Prenatal ethanol exposure impairs executive function in mice into adulthood. , 2014, Alcoholism, clinical and experimental research.

[54]  Nicholas A Hamilton,et al.  An integrated pipeline for the multidimensional analysis of branching morphogenesis , 2014, Nature Protocols.

[55]  A. Eschenroeder,et al.  The Opioid System and Brain Development: Effects of Methadone on the Oligodendrocyte Lineage and the Early Stages of Myelination , 2014, Developmental Neuroscience.

[56]  P. Kocherlakota.  Neonatal Abstinence Syndrome , 2014, Pediatrics.

[57]  S. Robinson,et al.  Complex pattern of interaction between in utero hypoxia-ischemia and intra-amniotic inflammation disrupts brain development and motor function , 2014, Journal of Neuroinflammation.

[58]  Christopher G. Wilson,et al.  Erythropoietin attenuates loss of potassium chloride co-transporters following prenatal brain injury , 2014, Molecular and Cellular Neuroscience.

[59]  S. Hernández-Díaz,et al.  Increase in Prescription Opioid Use During Pregnancy Among Medicaid-Enrolled Women , 2014, Obstetrics and gynecology.

[60]  S. Hernández-Díaz,et al.  Patterns of Opioid Utilization in Pregnancy in a Large Cohort of Commercial Insurance Beneficiaries in the United States , 2014, Anesthesiology.

[61]  R. Joseph,et al.  Elevated blood levels of inflammation-related proteins are associated with an attention problem at age 24 mo in extremely preterm infants , 2014, Pediatric Research.

[62]  Steven P. Miller,et al.  Brain injury in premature neonates: A primary cerebral dysmaturation disorder? , 2014, Annals of neurology.

[63]  D. Tappin,et al.  Reduced fetal growth in methadone-maintained pregnancies is not fully explained by smoking or socio-economic deprivation. , 2014, Addiction.

[64]  W. Bobo,et al.  Increasing pregnancy-related use of prescribed opioid analgesics. , 2013, Annals of epidemiology.

[65]  L. Saksida,et al.  GluN2B in corticostriatal circuits governs choice learning and choice shifting , 2013, Nature Neuroscience.

[66]  K. Blomgren,et al.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species , 2013, Progress in Neurobiology.

[67]  S. Hooper,et al.  The Consequences of Chorioamnionitis: Preterm Birth and Effects on Development , 2013, Journal of pregnancy.

[68]  M. H. Ensom,et al.  Dosing and monitoring of methadone in pregnancy: literature review. , 2012, The Canadian journal of hospital pharmacy.

[69]  S. Maier,et al.  Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement , 2012, The Journal of Neuroscience.

[70]  R. Ransohoff,et al.  Chemokine receptor CXCR2: Physiology regulator and neuroinflammation controller? , 2012, Journal of Neuroimmunology.

[71]  J. McAllister,et al.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. , 2012, JAMA.

[72]  Mark R Hutchinson,et al.  (+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats. , 2012, The journal of pain : official journal of the American Pain Society.

[73]  M. Hutchinson,et al.  Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. , 2012, Pharmacology & therapeutics.

[74]  L. Milio,et al.  Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes. , 2012, Drug and alcohol dependence.

[75]  C. Metz,et al.  Magnesium sulfate reduces bacterial LPS-induced inflammation at the maternal-fetal interface. , 2012, Placenta.

[76]  D. Hirtz,et al.  Elevated concentrations of inflammation-related proteins in postnatal blood predict severe developmental delay at 2 years of age in extremely preterm infants. , 2012, The Journal of pediatrics.

[77]  M. Hudak,et al.  Neonatal Drug Withdrawal , 2012, Pediatrics.

[78]  L. D. de Vries,et al.  Neonatal Tract-Based Spatial Statistics Findings and Outcome in Preterm Infants , 2012, American Journal of Neuroradiology.

[79]  L. Saksida,et al.  Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF , 2011, Nature Neuroscience.

[80]  S. Mackey,et al.  Prescription opioid analgesics rapidly change the human brain , 2011, PAIN®.

[81]  T. O'Shea,et al.  The relationship between early concentrations of 25 blood proteins and cerebral white matter injury in preterm newborns: the ELGAN study. , 2011, The Journal of pediatrics.

[82]  T. O'Shea,et al.  Early postnatal blood concentrations of inflammation-related proteins and microcephaly two years later in infants born before the 28th post-menstrual week. , 2011, Early human development.

[83]  H. Jones,et al.  Fetal neurobehavioral effects of exposure to methadone or buprenorphine. , 2011, Neurotoxicology and teratology.

[84]  W. Whetstone,et al.  Age Is a Determinant of Leukocyte Infiltration and Loss of Cortical Volume after Traumatic Brain Injury , 2010, Developmental Neuroscience.

[85]  Chao-Ching Huang,et al.  Altered inflammatory responses in preterm children with cerebral palsy , 2010, Annals of neurology.

[86]  L. Woodward,et al.  Maternal methadone dose during pregnancy and infant clinical outcome. , 2010, Neurotoxicology and teratology.

[87]  S. Drăghici,et al.  ORIGINAL ARTICLE: The Transcriptome of the Fetal Inflammatory Response Syndrome , 2009, American journal of reproductive immunology.

[88]  Mark R Hutchinson,et al.  The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. , 2009, Trends in pharmacological sciences.

[89]  S. Maier,et al.  Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia , 2008, Brain, Behavior, and Immunity.

[90]  E. Sanchez,et al.  Opioid addiction and pregnancy: Perinatal exposure to buprenorphine affects myelination in the developing brain , 2008, Glia.

[91]  J. Brigman,et al.  Stimulus specific deficit on visual reversal learning after lesions of medial prefrontal cortex in the mouse , 2008, Behavioural Brain Research.

[92]  L. Saksida,et al.  Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit. , 2008, Learning & memory.

[93]  Kirk W. Johnson,et al.  Opioid-Induced Glial Activation: Mechanisms of Activation and Implications for Opioid Analgesia, Dependence, and Reward , 2007, TheScientificWorldJournal.

[94]  F. Ghezzi,et al.  The fetal inflammatory response syndrome. , 2007, American journal of obstetrics and gynecology.

[95]  J. Hauth,et al.  The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. , 2006, American journal of obstetrics and gynecology.

[96]  J. W. Rudy,et al.  Neonatal Infection-Induced Memory Impairment after Lipopolysaccharide in Adulthood Is Prevented via Caspase-1 Inhibition , 2005, The Journal of Neuroscience.

[97]  J. W. Rudy,et al.  Neonatal infection induces memory impairments following an immune challenge in adulthood. , 2005, Behavioral neuroscience.

[98]  W. Poole,et al.  The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. , 2004, Pediatrics.

[99]  Roberto Romero,et al.  The fetal inflammatory response syndrome. , 1998, American journal of obstetrics and gynecology.

[100]  F. Ghezzi,et al.  A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. , 1998, American journal of obstetrics and gynecology.

[101]  R. Naeye,et al.  Chorioamnionitis, cortisol, and acute lung disease in very low birth weight infants. , 1997, Pediatrics.

[102]  K. Watterberg,et al.  Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. , 1996, Pediatrics.

[103]  S. Gabriel,et al.  Growth hormone pulsatility and the endocrine milieu during sexual maturation in male and female rats. , 1992, Neuroendocrinology.

[104]  I. Zagon,et al.  Perinatal methadone exposure and its influence on the behavioral ontogeny of rats , 1978, Pharmacology Biochemistry and Behavior.

[105]  I. Zagon,et al.  PERINATAL METHADONE EXPOSURE AND BRAIN DEVELOPMENT: A BIOCHEMICAL STUDY 1 , 1978, Journal of neurochemistry.

[106]  Janani Krishnaswami,et al.  Biopsychosocial determinants of opioid use disorder (OUD) and implications for maternal and child health research: A scoping review. , 2019, Journal of opioid management.

[107]  D. Maguire,et al.  Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome , 2016, Neonatal Network.

[108]  T. Heeren,et al.  The breadth and type of systemic inflammation and the risk of adverse neurological outcomes in extremely low gestation newborns. , 2015, Pediatric neurology.

[109]  A. Whittaker.  Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy By World Health Organization Geneva, Switzerland: WHO Press, 2014ISBN: 9789241548731, 224 pp. Available free online http://www.who.int/substance_abuse/publications/pregnancy_guidelines/en/ , 2015 .

[110]  L. Watkins,et al.  Discovery of a novel site of opioid action at the innate immune pattern-recognition receptor TLR4 and its role in addiction. , 2014, International review of neurobiology.

[111]  T. O'Shea,et al.  Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. , 2011, Cytokine.

[112]  G. Hankins,et al.  Bidirectional transfer of methadone across human placenta. , 2005, Biochemical pharmacology.

[113]  B. Ward,et al.  Fetal origin of amniotic fluid polymorphonuclear leukocytes. , 1997, American journal of obstetrics and gynecology.

[114]  E. Gerdin,et al.  Transplacental transfer of morphine in man , 1990, Journal of perinatal medicine.

[115]  I. Zagon,et al.  Perinatal Methadone Exposure in Rats , 1978 .